We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle Corp. (ALB - Free Report) is a global leader in providing essential elements for mobility, energy, connectivity, and health. Analysts have taken their earnings expectations lower over the last several months, pushing the stock into an unfavorable Zacks Rank #5 (Strong Sell).
Image Source: Zacks Investment Research
In addition, the company currently resides in the Zacks Chemical – Diversified industry, which is currently ranked in the bottom 10% of all Zacks industries. Let’s take a closer look at a few other aspects of the company.
Albemarle
Shares have had a rough showing over the past year, down more than 50% and widely underperforming relative to the S&P 500. Recent quarterly prints haven’t supported shares much, moving lower post-earnings in back-to-back releases.
Image Source: Zacks Investment Research
Concerning its latest quarterly release, the company fell short of the Zacks Consensus EPS estimate by nearly 26% and posted sales 3.4% below expectations. Falling lithium prices have stunted ALB’s growth, as we can see illustrated below.
Image Source: Zacks Investment Research
It’s worth noting that the company is scheduled to reveal its next set of results on February 14th after the market’s close. Analysts have taken revenue expectations lower along with earnings expectations, with the $2.3 billion expected down nearly 7% since last November.
Image Source: Zacks Investment Research
The unfavorable price action has boosted ALB’s yield, with shares now paying out 1.4% annually paired with a sustainable 8% payout ratio. Albemarle has also shown a nice commitment to increasingly rewarding shareholders, currently carrying a 2% five-year annualized dividend growth rate.
Image Source: Zacks Investment Research
Bottom Line
Negative earnings estimate revisions from analysts stemming from falling lithium prices paint a challenging picture for the company’s shares in the near term.
Albemarle (ALB - Free Report) is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company’s earnings outlook.
For those seeking strong stocks, a great idea would be to focus on stocks carrying a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy) – these stocks sport a notably stronger earnings outlook paired with the potential to deliver explosive gains in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: Albemarle (ALB)
Albemarle Corp. (ALB - Free Report) is a global leader in providing essential elements for mobility, energy, connectivity, and health. Analysts have taken their earnings expectations lower over the last several months, pushing the stock into an unfavorable Zacks Rank #5 (Strong Sell).
Image Source: Zacks Investment Research
In addition, the company currently resides in the Zacks Chemical – Diversified industry, which is currently ranked in the bottom 10% of all Zacks industries. Let’s take a closer look at a few other aspects of the company.
Albemarle
Shares have had a rough showing over the past year, down more than 50% and widely underperforming relative to the S&P 500. Recent quarterly prints haven’t supported shares much, moving lower post-earnings in back-to-back releases.
Image Source: Zacks Investment Research
Concerning its latest quarterly release, the company fell short of the Zacks Consensus EPS estimate by nearly 26% and posted sales 3.4% below expectations. Falling lithium prices have stunted ALB’s growth, as we can see illustrated below.
Image Source: Zacks Investment Research
It’s worth noting that the company is scheduled to reveal its next set of results on February 14th after the market’s close. Analysts have taken revenue expectations lower along with earnings expectations, with the $2.3 billion expected down nearly 7% since last November.
Image Source: Zacks Investment Research
The unfavorable price action has boosted ALB’s yield, with shares now paying out 1.4% annually paired with a sustainable 8% payout ratio. Albemarle has also shown a nice commitment to increasingly rewarding shareholders, currently carrying a 2% five-year annualized dividend growth rate.
Image Source: Zacks Investment Research
Bottom Line
Negative earnings estimate revisions from analysts stemming from falling lithium prices paint a challenging picture for the company’s shares in the near term.
Albemarle (ALB - Free Report) is a Zacks Rank #5 (Strong Sell), indicating that analysts have taken a bearish stance on the company’s earnings outlook.
For those seeking strong stocks, a great idea would be to focus on stocks carrying a Zacks Rank #1 (Strong Buy) or a Zacks Rank #2 (Buy) – these stocks sport a notably stronger earnings outlook paired with the potential to deliver explosive gains in the near term.